Anti-Platelet Therapy Post-PCI in Patients on an Oral Anti-coagulant: Too Much or Too Little?
Presenter
Dharam J. Kumbhani, M.D., FSCAI, University of Texas Southwestern, Dallas, TX
Dharam J. Kumbhani, M.D., FSCAI, University of Texas Southwestern, Dallas, TX
Learning Objectives:
- Discuss bleeding risk of triple therapy post-PCI.
- Recognize ischemia risk post-PCI in a patient on a single or no anti-platelet agent and oral anti-coagulation.
- Identify various anti-platelet and oral anti-coagulation options post-PCI.
Keywords: Coronary, Drug-eluting Stent (DES) and Pharmacotherapy